Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Auxilium Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Auxilium Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Auxilium Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is AUXL. The reporting company's CIK number is 1182129.
The total value of stock buying since 2005 is $86,216,202.
The total value of stock sales since 2005 is $85,896,601.
The total value of stock option exercises since 2005 is $22,897,152.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-12 | 0 | $0 | 499,254 | $16,905,025 | 460,000 | $8,504,780 |
| 2014-11 | 0 | $0 | 536,193 | $17,881,406 | 492,724 | $9,971,916 |
| 2014-03 | 0 | $0 | 42,032 | $1,264,481 | 41,508 | $494,056 |
| 2013-12 | 0 | $0 | 75,669 | $1,541,762 | 75,367 | $396,288 |
| 2013-08 | 0 | $0 | 1,900 | $35,649 | 0 | $0 |
| 2013-05 | 0 | $0 | 2,000 | $30,208 | 0 | $0 |
| 2012-12 | 56,000 | $0 | 0 | $0 | 0 | $0 |
| 2012-06 | 0 | $0 | 18,682 | $452,463 | 18,682 | $124,651 |
| 2012-02 | 10,000 | $200,970 | 0 | $0 | 0 | $0 |
| 2011-11 | 1,610 | $25,024 | 0 | $0 | 0 | $0 |
| 2011-10 | 0 | $0 | 5,275 | $75,047 | 5,275 | $41,197 |
| 2011-07 | 0 | $0 | 5,275 | $107,103 | 5,275 | $41,197 |
| 2011-03 | 1,536,618 | $35,014,064 | 10,555 | $242,997 | 10,555 | $82,434 |
| 2011-01 | 0 | $0 | 10,555 | $245,055 | 10,555 | $82,434 |
| 2010-08 | 113,599 | $2,896,595 | 0 | $0 | 0 | $0 |
| 2010-05 | 0 | $0 | 0 | $0 | 18,750 | $107,193 |
| 2010-04 | 0 | $0 | 56,068 | $1,937,134 | 56,068 | $352,360 |
| 2010-03 | 135,272 | $4,391,953 | 0 | $0 | 0 | $0 |
| 2009-09 | 0 | $0 | 54,883 | $1,884,474 | 41,733 | $318,305 |
| 2009-07 | 0 | $0 | 10,883 | $341,090 | 10,333 | $77,529 |
| 2009-06 | 0 | $0 | 34,000 | $1,017,750 | 34,000 | $253,420 |
| 2009-05 | 0 | $0 | 4,000 | $100,092 | 4,000 | $19,120 |
| 2009-04 | 0 | $0 | 4,000 | $100,031 | 4,000 | $19,120 |
| 2009-03 | 0 | $0 | 34,933 | $1,038,914 | 34,933 | $257,879 |
| 2009-02 | 0 | $0 | 5,300 | $168,519 | 1,850 | $24,771 |
| 2009-01 | 0 | $0 | 16,122 | $480,188 | 11,520 | $129,375 |
| 2008-12 | 0 | $0 | 16,675 | $445,092 | 5,000 | $26,800 |
| 2008-08 | 0 | $0 | 8,750 | $350,525 | 8,750 | $115,150 |
| 2008-07 | 0 | $0 | 98,340 | $3,547,282 | 98,340 | $918,880 |
| 2008-05 | 0 | $0 | 90,750 | $2,763,337 | 90,750 | $447,397 |
| 2007-09 | 0 | $0 | 177,232 | $3,552,498 | 0 | $0 |
| 2007-08 | 0 | $0 | 250,374 | $5,025,369 | 0 | $0 |
| 2007-05 | 1,510 | $20,196 | 15,000 | $199,890 | 15,000 | $90,900 |
| 2006-12 | 0 | $0 | 1,510,000 | $24,163,220 | 0 | $0 |
| 2006-03 | 5,500 | $35,365 | 0 | $0 | 0 | $0 |
| 2005-11 | 15,000 | $73,145 | 0 | $0 | 0 | $0 |
| 2005-06 | 8,889,570 | $43,558,890 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-12-05 | Lurker Nancy (Director) | Sale | 32,430 | 34.00 | 1,102,620 |
| 2014-12-05 | Lurker Nancy (Director) | Option Ex | 25,000 | 19.59 | 489,750 |
| 2014-12-05 | Adams Adrian (CEO and President) | Sale | 40,000 | 33.97 | 1,358,720 |
| 2014-12-05 | Adams Adrian (CEO and President) | Option Ex | 40,000 | 17.40 | 696,000 |
| 2014-12-05 | Mckee William (Director) | Sale | 18,000 | 34.00 | 612,000 |
| 2014-12-05 | Mckee William (Director) | Option Ex | 15,000 | 30.61 | 459,150 |
| 2014-12-05 | Friedman Paul A (Director) | Sale | 9,689 | 33.85 | 327,953 |
| 2014-12-04 | Friedman Paul A (Director) | Sale | 20,000 | 33.67 | 673,460 |
| 2014-12-04 | Friedman Paul A (Director) | Option Ex | 20,000 | 17.08 | 341,500 |
| 2014-12-03 | Fetzer Oliver (Director) | Sale | 50,000 | 34.00 | 1,700,000 |
| 2014-12-03 | Fetzer Oliver (Director) | Option Ex | 50,000 | 22.90 | 1,144,800 |
| 2014-12-02 | Fetzer Oliver (Director) | Sale | 50,000 | 34.03 | 1,701,650 |
| 2014-12-02 | Fetzer Oliver (Director) | Option Ex | 50,000 | 14.22 | 711,000 |
| 2014-12-02 | Classon Rolf A (Director) | Sale | 279,135 | 33.78 | 9,428,622 |
| 2014-12-02 | Classon Rolf A (Director) | Option Ex | 260,000 | 17.93 | 4,662,580 |
| 2014-11-25 | Jobes Elizabeth Varki (Chief Compliance Officer) | Sale | 27,802 | 34.04 | 946,407 |
| 2014-11-25 | Jobes Elizabeth Varki (Chief Compliance Officer) | Option Ex | 23,750 | 17.99 | 427,262 |
| 2014-11-25 | Tursi James Patrick (Chief Medical Officer) | Sale | 13,713 | 34.12 | 467,942 |
| 2014-11-25 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 10,562 | 20.17 | 213,035 |
| 2014-11-21 | Armstrong Jennifer Lou (Senior Vice President, HR) | Sale | 75,803 | 33.50 | 2,539,097 |
| 2014-11-21 | Armstrong Jennifer Lou (Senior Vice President, HR) | Option Ex | 69,412 | 22.84 | 1,585,161 |
| 2014-11-21 | Tursi James Patrick (Chief Medical Officer) | Sale | 8,648 | 33.47 | 289,413 |
| 2014-11-21 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 5,000 | 22.04 | 110,200 |
| 2014-11-21 | Koven Andrew I (EVP, CAO, GC and Secretary) | Sale | 139,683 | 33.44 | 4,670,720 |
| 2014-11-21 | Koven Andrew I (EVP, CAO, GC and Secretary) | Option Ex | 134,375 | 19.18 | 2,577,984 |
| 2014-11-20 | Tursi James Patrick (Chief Medical Officer) | Sale | 66,000 | 33.06 | 2,181,960 |
| 2014-11-20 | Tursi James Patrick (Chief Medical Officer) | Option Ex | 66,000 | 16.80 | 1,109,130 |
| 2014-11-20 | Wills Alan (EVP, Corporate Development) | Sale | 156,592 | 33.18 | 5,195,252 |
| 2014-11-20 | Wills Alan (EVP, Corporate Development) | Option Ex | 142,875 | 21.44 | 3,062,954 |
| 2014-11-20 | Glickman Mark A (EVP - Sales and Marketing) | Sale | 47,952 | 33.17 | 1,590,615 |
| 2014-11-20 | Glickman Mark A (EVP - Sales and Marketing) | Option Ex | 40,750 | 21.75 | 886,190 |
| 2014-03-14 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Sale | 32,032 | 29.53 | 946,001 |
| 2014-03-14 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Option Ex | 31,508 | 13.30 | 419,056 |
| 2014-03-05 | Classon Rolf A (Director) | Sale | 10,000 | 31.85 | 318,480 |
| 2014-03-05 | Classon Rolf A (Director) | Option Ex | 10,000 | 7.50 | 75,000 |
| 2013-12-13 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Sale | 4,602 | 20.50 | 94,341 |
| 2013-12-13 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Option Ex | 4,300 | 13.16 | 56,588 |
| 2013-12-11 | Fickenscher James E (Chief Financial Officer) | Sale | 71,067 | 20.37 | 1,447,421 |
| 2013-12-11 | Fickenscher James E (Chief Financial Officer) | Option Ex | 71,067 | 4.78 | 339,700 |
| 2013-08-15 | Fetzer Oliver (Director) | Sale | 1,900 | 18.76 | 35,649 |
| 2013-05-20 | Mckee William (Director) | Sale | 2,000 | 15.10 | 30,208 |
| 2012-12-14 | Adams Adrian (CEO and President) | Buy | 56,000 | .00 | 0 |
| 2012-06-25 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Sale | 12,682 | 25.01 | 317,151 |
| 2012-06-25 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Option Ex | 12,682 | 5.50 | 69,751 |
| 2012-06-06 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Sale | 6,000 | 22.55 | 135,312 |
| 2012-06-06 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Option Ex | 6,000 | 9.15 | 54,900 |
| 2012-02-28 | Brandt Peter C. (Director) | Buy | 10,000 | 20.10 | 200,970 |
| 2011-11-03 | Fickenscher James E (Chief Financial Officer) | Buy | 1,610 | 15.54 | 25,024 |
| 2011-10-07 | Anido Armando (CEO & President) | Sale | 5,275 | 14.23 | 75,047 |
| 2011-10-07 | Anido Armando (CEO & President) | Option Ex | 5,275 | 7.81 | 41,197 |
| 2011-07-08 | Anido Armando (CEO & President) | Sale | 5,275 | 20.30 | 107,103 |
| 2011-07-08 | Anido Armando (CEO & President) | Option Ex | 5,275 | 7.81 | 41,197 |
| 2011-03-30 | Baker Felix (10% Owner) | Buy | 3,911 | 21.98 | 85,963 |
| 2011-03-30 | Baker Julian (10% Owner) | Buy | 309 | 21.98 | 6,791 |
| 2011-03-29 | Baker Julian (10% Owner) | Buy | 332,000 | 21.97 | 7,292,712 |
| 2011-03-09 | Baker Felix (10% Owner) | Buy | 782,273 | 23.12 | 18,086,151 |
| 2011-03-08 | Anido Armando (CEO & President) | Sale | 10,555 | 23.02 | 242,997 |
| 2011-03-08 | Anido Armando (CEO & President) | Option Ex | 10,555 | 7.81 | 82,434 |
| 2011-03-08 | Baker Felix (10% Owner) | Buy | 211,909 | 22.82 | 4,836,186 |
| 2011-01-10 | Anido Armando (CEO & President) | Sale | 10,555 | 23.22 | 245,055 |
| 2011-01-10 | Anido Armando (CEO & President) | Option Ex | 10,555 | 7.81 | 82,434 |
| 2010-08-27 | Baker Felix (10% Owner) | Buy | 964 | 25.80 | 24,876 |
| 2010-08-27 | Baker Julian (10% Owner) | Buy | 34,899 | 25.80 | 900,568 |
| 2010-08-26 | Baker Felix (10% Owner) | Buy | 2,088 | 25.36 | 52,945 |
| 2010-08-26 | Baker Julian (10% Owner) | Buy | 75,648 | 25.36 | 1,918,206 |
| 2010-05-27 | Bescherer Edwin A Jr (Director) | Option Ex | 18,750 | 5.72 | 107,193 |
| 2010-04-26 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Sale | 7,318 | 35.67 | 261,062 |
| 2010-04-26 | Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) | Option Ex | 7,318 | 5.50 | 40,249 |
| 2010-04-19 | Bescherer Edwin A Jr (Director) | Sale | 12,500 | 36.48 | 455,962 |
| 2010-04-19 | Bescherer Edwin A Jr (Director) | Option Ex | 12,500 | 4.15 | 51,874 |
| 2010-04-12 | Anido Armando (CEO & President) | Sale | 30,000 | 33.07 | 992,129 |
| 2010-04-12 | Anido Armando (CEO & President) | Option Ex | 30,000 | 7.81 | 234,300 |
| 2010-03-11 | Baker Felix (10% Owner) | Buy | 1,805 | 34.10 | 61,554 |
| 2010-03-11 | Baker Julian (10% Owner) | Buy | 15,367 | 34.10 | 524,045 |
| 2010-03-10 | Baker Felix (10% Owner) | Buy | 1,203 | 33.19 | 39,923 |
| 2010-03-10 | Baker Julian (10% Owner) | Buy | 43,597 | 33.19 | 1,446,853 |
| 2010-03-09 | Baker Felix (10% Owner) | Buy | 1,969 | 31.64 | 62,309 |
| 2010-03-09 | Baker Julian (10% Owner) | Buy | 71,331 | 31.64 | 2,257,269 |
| 2009-09-25 | Bescherer Edwin A Jr (Director) | Sale | 27,600 | 34.83 | 961,308 |
| 2009-09-25 | Bescherer Edwin A Jr (Director) | Option Ex | 15,000 | 3.71 | 55,620 |
| 2009-09-14 | Fickenscher James E (Chief Financial Officer) | Sale | 4,000 | 30.70 | 122,812 |
| 2009-09-14 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-09-14 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Sale | 12,950 | 35.21 | 455,956 |
| 2009-09-14 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Option Ex | 12,400 | 13.39 | 166,036 |
| 2009-09-14 | Stacey Jennifer Evans (Executive VP & General Counsel) | Sale | 6,333 | 35.43 | 224,390 |
| 2009-09-14 | Stacey Jennifer Evans (Executive VP & General Counsel) | Option Ex | 6,333 | 9.22 | 58,409 |
| 2009-09-08 | Fickenscher James E (Chief Financial Officer) | Sale | 4,000 | 30.00 | 120,008 |
| 2009-09-08 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-07-24 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Sale | 550 | 32.00 | 17,600 |
| 2009-07-24 | Stacey Jennifer Evans (Executive VP & General Counsel) | Sale | 6,333 | 32.13 | 203,466 |
| 2009-07-24 | Stacey Jennifer Evans (Executive VP & General Counsel) | Option Ex | 6,333 | 9.22 | 58,409 |
| 2009-07-15 | Fickenscher James E (Chief Financial Officer) | Sale | 4,000 | 30.01 | 120,024 |
| 2009-07-15 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-06-26 | Anido Armando (CEO & President) | Sale | 30,000 | 30.30 | 908,910 |
| 2009-06-26 | Anido Armando (CEO & President) | Option Ex | 30,000 | 7.81 | 234,300 |
| 2009-06-15 | Fickenscher James E (Chief Financial Officer) | Sale | 4,000 | 27.21 | 108,840 |
| 2009-06-15 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-05-22 | Fickenscher James E (Chief Financial Officer) | Sale | 4,000 | 25.02 | 100,092 |
| 2009-05-22 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-04-17 | Fickenscher James E (Chief Financial Officer) | Sale | 500 | 25.00 | 12,500 |
| 2009-04-17 | Fickenscher James E (Chief Financial Officer) | Option Ex | 500 | 4.78 | 2,390 |
| 2009-04-16 | Fickenscher James E (Chief Financial Officer) | Sale | 3,500 | 25.01 | 87,531 |
| 2009-04-16 | Fickenscher James E (Chief Financial Officer) | Option Ex | 3,500 | 4.78 | 16,730 |
| 2009-03-16 | Fickenscher James E (Chief Financial Officer) | Sale | 4,933 | 29.79 | 146,954 |
| 2009-03-16 | Fickenscher James E (Chief Financial Officer) | Option Ex | 4,933 | 4.78 | 23,579 |
| 2009-03-16 | Anido Armando (CEO & President) | Sale | 30,000 | 29.73 | 891,960 |
| 2009-03-16 | Anido Armando (CEO & President) | Option Ex | 30,000 | 7.81 | 234,300 |
| 2009-02-17 | Fickenscher James E (Chief Financial Officer) | Sale | 3,450 | 31.55 | 108,837 |
| 2009-02-03 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Sale | 1,850 | 32.26 | 59,682 |
| 2009-02-03 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Option Ex | 1,850 | 13.39 | 24,771 |
| 2009-01-14 | Fickenscher James E (Chief Financial Officer) | Sale | 3,942 | 29.04 | 114,463 |
| 2009-01-06 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Sale | 6,210 | 30.02 | 186,393 |
| 2009-01-06 | Graham Roger D Jr (Executive VP, Sales & Mktg) | Option Ex | 5,550 | 13.39 | 74,314 |
| 2009-01-06 | Stacey Jennifer Evans (Executive VP & General Counsel) | Sale | 5,970 | 30.04 | 179,332 |
| 2009-01-06 | Stacey Jennifer Evans (Executive VP & General Counsel) | Option Ex | 5,970 | 9.22 | 55,061 |
| 2008-12-19 | Fickenscher James E (Chief Financial Officer) | Sale | 11,675 | 26.31 | 307,122 |
| 2008-12-18 | Stacey Jennifer Evans (Executive VP & General Counsel) | Sale | 5,000 | 27.59 | 137,970 |
| 2008-12-18 | Stacey Jennifer Evans (Executive VP & General Counsel) | Option Ex | 5,000 | 5.36 | 26,800 |
| 2008-08-12 | Mattila Jyrki (Executive Vice President) | Sale | 8,750 | 40.06 | 350,525 |
| 2008-08-12 | Mattila Jyrki (Executive Vice President) | Option Ex | 8,750 | 13.16 | 115,150 |
| 2008-07-16 | Mattila Jyrki (Executive Vice President) | Sale | 24,000 | 38.09 | 914,160 |
| 2008-07-16 | Mattila Jyrki (Executive Vice President) | Option Ex | 24,000 | 12.50 | 300,000 |
| 2008-07-15 | Mattila Jyrki (Executive Vice President) | Sale | 74,340 | 35.42 | 2,633,122 |
| 2008-07-15 | Mattila Jyrki (Executive Vice President) | Option Ex | 74,340 | 8.32 | 618,880 |
| 2008-05-07 | Mattila Jyrki (Executive Vice President) | Sale | 90,750 | 30.45 | 2,763,337 |
| 2008-05-07 | Mattila Jyrki (Executive Vice President) | Option Ex | 90,750 | 4.93 | 447,397 |
| 2007-09-06 | Credit Suisse/ (10% Owner) | Sale | 116,913 | 20.11 | 2,350,886 |
| 2007-09-05 | Credit Suisse/ (10% Owner) | Sale | 45,319 | 20.06 | 908,872 |
| 2007-09-04 | Bescherer Edwin A Jr (Director) | Sale | 15,000 | 19.52 | 292,740 |
| 2007-08-24 | Credit Suisse/ (10% Owner) | Sale | 193,778 | 20.07 | 3,889,318 |
| 2007-08-22 | Credit Suisse/ (10% Owner) | Sale | 56,596 | 20.07 | 1,136,051 |
| 2007-05-08 | Fickenscher James E (Chief Financial Officer) | Buy | 1,510 | 13.38 | 20,196 |
| 2007-05-08 | Altomari Alfred (Director) | Sale | 15,000 | 13.33 | 199,890 |
| 2007-05-08 | Altomari Alfred (Director) | Option Ex | 15,000 | 6.06 | 90,900 |
| 2006-12-05 | Soros George (10% Owner) | Sale | 1,500,000 | 16.00 | 24,000,000 |
| 2006-12-01 | Bescherer Edwin A Jr (Director) | Sale | 10,000 | 16.32 | 163,220 |
| 2006-03-10 | Kessig Edward F (Vice President, Sales) | Buy | 3,500 | 6.43 | 22,505 |
| 2006-03-10 | Fickenscher James E (Chief Financial Officer) | Buy | 1,000 | 6.43 | 6,430 |
| 2006-03-10 | Henwood Geraldine (Chief Executive Officer) | Buy | 1,000 | 6.43 | 6,430 |
| 2005-11-28 | Stacey Jennifer Evans (General Counsel) | Buy | 5,000 | 5.32 | 26,605 |
| 2005-11-22 | Classon Rolf A (Director) | Buy | 5,000 | 5.09 | 25,450 |
| 2005-11-11 | Fickenscher James E (Chief Financial Officer) | Buy | 5,000 | 4.22 | 21,090 |
| 2005-06-30 | Scp Private Equity Ii Llc (10% Owner) | Buy | 1,322,112 | 4.90 | 6,478,348 |
| 2005-06-30 | Churchill Winston J (Director) | Buy | 3,042,081 | 4.90 | 14,906,196 |
| 2005-06-30 | Soros George (10% Owner) | Buy | 1,224,178 | 4.90 | 5,998,472 |
Insider trading activities including stock purchases, stock sales, and option exercises of AUXL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Auxilium Pharmaceuticals Inc (symbol AUXL, CIK number 1182129) see the Securities and Exchange Commission (SEC) website.